LAVAL, QC / ACCESSWIRE / January 30, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its dermatology business, Ortho Dermatologics, today announced the U.S. launch of CABTREO™ (clindamycin ...
LAVAL, QC / ACCESSWIRE / October 20, 2023 / Bausch Health Companies Inc. (NYSE:BHC) (TSX:BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, today announced that the U.S. Food ...
Please provide your email address to receive an email when new articles are posted on . The triple-combination gel was much more evenly applied than the layered ingredients in 100% of cases. 96% of ...
LAVAL, QC / ACCESS Newswire / August 21, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced that ...
Anyone who’s experienced acne knows how difficult and frustrating it can be to treat. Differin Gel is the first and only over-the-counter (OTC) retinoid acne treatment that’s been approved by the Food ...
Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% (CAB) gel was shown to be safe and effective in Hispanic and Latino populations with moderate-to-severe acne. The post hoc analysis ...